The Pharmacological Treatment of Chronic Pain: From Guidelines to Daily Clinical Practice

被引：20

作者：

Marciano, Gianmarco ^{[1
]}

Vocca, Cristina ^{[1
]}

Evangelista, Maurizio ^{[2
]}

Palleria, Caterina ^{[1
]}

Muraca, Lucia ^{[3
]}

Galati, Cecilia ^{[4
]}

Monea, Francesco ^{[4
]}

Sportiello, Liberata ^{[5
,6
]}

De Sarro, Giovambattista ^{[1
,4
]}

Capuano, Annalisa ^{[5
,6
]}

Gallelli, Luca ^{[1
,4
,7
,8
]}

机构：

[1] Mater Domini Hosp, Operat Unit Pharmacol & Pharmacovigilance, I-88100 Catanzaro, Italy

[2] Sacred Heart Catholic Univ, Dept Anesthesia Resuscitat & Pain Therapy, I-00100 Rome, Italy

[3] ASP 7, Dept Primary Care, I-88100 Catanzaro, Italy

[4] Magna Graecia Univ Catanzaro, Res Ctr FAS UMG, Dept Hlth Sci, I-88100 Catanzaro, Italy

[5] Campania Reg Ctr Pharmacovigilance & Pharmacoepide, I-80138 Naples, Italy

[6] Univ Campania Luigi Vanvitelli, Dept Expt Med, Sect Pharmacol L Donatelli, Via Costantinopoli 16, I-80138 Naples, Italy

[7] Univ Catanzaro, Medifarmagen Srl, I-88100 Catanzaro, Italy

[8] Mater Domini Hosp, I-88100 Catanzaro, Italy

来源：

PHARMACEUTICS | 2023年 / 15卷 / 04期

关键词：

nociceptive pain; neuropathic pain; nociplastic pain; drug treatment; drug interactions; guidelines; ADVERSE DRUG-REACTIONS; CHRONIC KIDNEY-DISEASE; ACETYL-L-CARNITINE; AMERICAN-SOCIETY; OPIOID THERAPY; DOUBLE-BLIND; MANAGEMENT; RISK; AMITRIPTYLINE; DULOXETINE;

D O I：

10.3390/pharmaceutics15041165

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

In agreement with the International Association for the Study of Pain, chronic pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage. To date, there are several types of pain: nociceptive, neuropathic, and nociplastic. In the present narrative review, we evaluated the characteristics of the drugs used for each type of pain, according to guidelines, and their effects in people with comorbidity to reduce the development of severe adverse events.

引用

页数：25

共 138 条

[1]

Abi-aad K.R., HYDROMORPHONE

[2]

AIFA, 2022, AG IT FARM RIASS CAR

[3]

AIFA, RIASS CAR PROD GAB

[4]

AIFA Agenzia Italiana del Farmaco, CYMB RIASS CAR PROD

[5]

AIFA Agenzia Italiana del Farmaco, PAR COD RIASS CAR PR

[6]

AIFA Agenzia Italiana del Farmaco Aspirina, 2021, RIASS CAR PROD

[7] Augmentation of Venlafaxine With Bupropion: Risks Associated With a Triple Monoamine Reuptake Inhibition Approach to Partially Responsive Depression [J].

Andrade, Chittaranjan .

JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (02) :E119-E121

[8]

[Anonymous], 2010, P & T

[9]

[Anonymous], 2019, Pain management best practices inter-agency task force report: Updates, gaps, inconsistencies, and recommendations, P116

[10]

[Anonymous], 2021, Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain, DOI DOI 10.1097/PR9.0000000000000961

← 1 2 3 4 5 6 7 8 9 10 →